Clinical Trials Browser

Phase 1 × Leukemia, Lymphocytic, Chronic, B-Cell × Dimethyl Fumarate × Clear all

NCT02784834 2019-09-19

Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL

Phase 1 Terminated

2 enrolled 5 charts

LymphoidOther hematologic neoplasm

Neoplasms, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell